[Federal Register: March 15, 2004 (Volume 69, Number 50)]
[Notices]               
[Page 12180]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr04-110]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manuafacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 29, 2004, Rhodes 
Technologies, 498 Washington Street, Coventry, Rhodes Island 02816, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Thebaine (9333)............................  II
Noroxymorphone (9668)......................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to produce bulk products for conversion and 
distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than May 14, 
2004.

    Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5781 Filed 3-12-04; 8:45 am]

BILLING CODE 4410-09-M